Inactivation or downregulation of PTEN is commonly seen in many cancers, including UCB [21], as PTEN regulates and opposes the oncogenic Phosphoinositide 3-kinase (PI3K)-Akt pathway, i.e., by dephosphorylation [22]. This evidence concerns the gene PTEN and cancer.